Follow the people · Insider
Elizabeth Bhatt
Elizabeth Bhatt files insider transactions with the SEC as a president and coo of Septerna (SEPN). We hold 4 disclosed purchases and sales filed since 13 September 2018, 2 of them in the last 90 days.
- Files forSEPN
- Disclosed buys and sells4 in all, 2 in the last 90 days
- Last disclosure13 August 2026
Positions held
5 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 7 August 2025 — 11 August 2026President and COO · Septerna (SEPN)24 Form 4 lines · source: SEC Form 4
- Filed 25 August 2021 — 13 June 2024Director · eFFECTOR Therapeutics (EFTR)9 Form 4 lines · source: SEC Form 4
- Filed 1 March 2021 — 15 February 2022Chief Bus. & Strategy Officer · Applied Molecular Transport (AMTI)13 Form 4 lines · source: SEC Form 4
- Filed 12 January 2021 — 12 January 2021Director · Locust Walk Acquisition (LWAC)1 Form 4 line · source: SEC Form 4
- Filed 11 September 2018 — 21 February 2019Chief Operating Officer · Achaogen (AKAO)4 Form 4 lines · source: SEC Form 4
Everything they disclosed
51 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 18,681 shares of SepternaSEC Form 413 August 2026Common Stock · traded 11 August 2026 · filed 13 August 2026
- exercised options over 6,319 shares of SepternaSEC Form 413 August 2026Common Stock · traded 11 August 2026 · filed 13 August 2026
- ▼ sold on the open market 25,000 shares of SepternaSEC Form 413 August 2026Common Stock · traded 11 August 2026 · filed 13 August 2026
- exercised options over 18,681 shares of Septerna (a derivative holding)SEC Form 413 August 2026Stock Option (Right to Buy) · traded 11 August 2026 · filed 13 August 2026
- exercised options over 6,319 shares of Septerna (a derivative holding)SEC Form 413 August 2026Stock Option (Right to Buy) · traded 11 August 2026 · filed 13 August 2026
- exercised options over 4,000 shares of SepternaSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 4,000 shares of SepternaSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- exercised options over 4,000 shares of Septerna (a derivative holding)SEC Form 417 July 2026Stock Option (Right to Buy) · traded 15 July 2026 · filed 17 July 2026
- exercised options over 4,000 shares of SepternaSEC Form 417 April 2026Common Stock · traded 15 April 2026 · filed 17 April 2026
- ▼ sold on the open market 2,573 shares of SepternaSEC Form 417 April 2026Common Stock · traded 15 April 2026 · filed 17 April 2026
- ▼ sold on the open market 1,101 shares of SepternaSEC Form 417 April 2026Common Stock · traded 15 April 2026 · filed 17 April 2026
- ▼ sold on the open market 326 shares of SepternaSEC Form 417 April 2026Common Stock · traded 15 April 2026 · filed 17 April 2026
- exercised options over 4,000 shares of Septerna (a derivative holding)SEC Form 417 April 2026Stock Option (Right to Buy) · traded 15 April 2026 · filed 17 April 2026
- exercised options over 4,000 shares of SepternaSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- ▼ sold on the open market 2,200 shares of SepternaSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- ▼ sold on the open market 1,800 shares of SepternaSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- exercised options over 4,000 shares of Septerna (a derivative holding)SEC Form 420 February 2026Stock Option (Right to Buy) · traded 18 February 2026 · filed 20 February 2026
- exercised options over 4,000 shares of Septerna (a derivative holding)SEC Form 420 February 2026Stock Option (Right to Buy) · traded 18 February 2026 · filed 20 February 2026
- exercised options over 4,000 shares of SepternaSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- ▼ sold on the open market 2,200 shares of SepternaSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- ▼ sold on the open market 1,800 shares of SepternaSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- was granted 155,000 shares of Septerna (a derivative holding)SEC Form 410 February 2026Stock Option (Right to Buy) · traded 6 February 2026 · filed 10 February 2026
- was granted 155,000 shares of Septerna (a derivative holding)SEC Form 410 February 2026Stock Option (Right to Buy) · traded 6 February 2026 · filed 10 February 2026
- was granted 95,000 shares of Septerna (a derivative holding)SEC Form 411 August 2025Stock Option (Right to Buy) · traded 7 August 2025 · filed 11 August 2025
- was granted 800 shares of eFFECTOR Therapeutics (a derivative holding)SEC Form 413 June 2024Stock Option (Right to Buy) · traded 13 June 2024 · filed 13 June 2024
- was granted 2,000 shares of eFFECTOR Therapeutics (a derivative holding)SEC Form 421 February 2024Stock Option (Right to Buy) · traded 19 February 2024 · filed 21 February 2024
- was granted 20,000 shares of eFFECTOR Therapeutics (a derivative holding)SEC Form 422 June 2023Stock Option (Right to Buy) · traded 22 June 2023 · filed 22 June 2023
- was granted 30,000 shares of eFFECTOR Therapeutics (a derivative holding)SEC Form 424 January 2023Stock Option (Right to Buy) · traded 20 January 2023 · filed 24 January 2023
- was granted 20,000 shares of eFFECTOR Therapeutics (a derivative holding)SEC Form 413 June 2022Stock Option (Right to Buy) · traded 9 June 2022 · filed 13 June 2022
- was granted 80,500 shares of Applied Molecular Transport (a derivative holding)SEC Form 416 February 2022Stock Option (Right to Buy) · traded 15 February 2022 · filed 16 February 2022
- was granted 17,250 shares of Applied Molecular TransportSEC Form 416 February 2022Common Stock · traded 15 February 2022 · filed 16 February 2022
- was granted 31,500 shares of Applied Molecular TransportSEC Form 46 January 2022Common Stock · traded 24 December 2021 · filed 6 January 2022
- was granted 40,000 shares of eFFECTOR Therapeutics (a derivative holding)SEC Form 48 October 2021Stock Option (Right to Buy) · traded 6 October 2021 · filed 8 October 2021
- returned to the issuer 8,453 shares of eFFECTOR Therapeutics (a derivative holding)SEC Form 427 August 2021Class B Common Stock · traded 25 August 2021 · filed 27 August 2021
- converted 9,047 shares of eFFECTOR Therapeutics (a derivative holding)SEC Form 427 August 2021Class B Common Stock · traded 25 August 2021 · filed 27 August 2021
- converted 9,047 shares of eFFECTOR TherapeuticsSEC Form 427 August 2021Class A Common Stock · traded 25 August 2021 · filed 27 August 2021
- exercised options over 9,000 shares of Applied Molecular TransportSEC Form 422 July 2021Common Stock · traded 21 July 2021 · filed 22 July 2021
- ▼ sold on the open market 6,640 shares of Applied Molecular TransportSEC Form 422 July 2021Common Stock · traded 21 July 2021 · filed 22 July 2021
- ▼ sold on the open market 2,360 shares of Applied Molecular TransportSEC Form 422 July 2021Common Stock · traded 21 July 2021 · filed 22 July 2021
- exercised options over 9,000 shares of Applied Molecular Transport (a derivative holding)SEC Form 422 July 2021Stock Option (Right to Buy) · traded 21 July 2021 · filed 22 July 2021
- exercised options over 9,000 shares of Applied Molecular Transport (a derivative holding)SEC Form 422 April 2021Stock Option (Right to Buy) · traded 21 April 2021 · filed 22 April 2021
- exercised options over 9,000 shares of Applied Molecular TransportSEC Form 422 April 2021Common Stock · traded 21 April 2021 · filed 22 April 2021
- ▼ sold on the open market 971 shares of Applied Molecular TransportSEC Form 422 April 2021Common Stock · traded 21 April 2021 · filed 22 April 2021
- ▼ sold on the open market 5,417 shares of Applied Molecular TransportSEC Form 422 April 2021Common Stock · traded 21 April 2021 · filed 22 April 2021
- ▼ sold on the open market 2,612 shares of Applied Molecular TransportSEC Form 422 April 2021Common Stock · traded 21 April 2021 · filed 22 April 2021
- was granted 63,000 shares of Applied Molecular Transport (a derivative holding)SEC Form 43 March 2021Stock Option (Right to Buy) · traded 1 March 2021 · filed 3 March 2021
- acquired or disposed of, other 17,500 shares of Locust Walk Acquisition (a derivative holding)SEC Form 414 January 2021Class B Common Stock · traded 12 January 2021 · filed 14 January 2021
- ▼ sold on the open market 971 shares of AchaogenSEC Form 425 February 2019Common Stock · traded 21 February 2019 · filed 25 February 2019
- was granted 60,000 shares of AchaogenSEC Form 423 January 2019Common Stock · traded 31 October 2018 · filed 23 January 2019
- was granted 156,500 shares of AchaogenSEC Form 423 January 2019Common Stock · traded 18 January 2019 · filed 23 January 2019
- was granted 65,000 shares of Achaogen (a derivative holding)SEC Form 413 September 2018Stock Option (Right to Buy) · traded 11 September 2018 · filed 13 September 2018
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.